Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic study of QingKaiLing injection in healthy subjects
ChiCTR-OPN-15006552Phase 4Recruiting
- Sponsor
- Institute of Chinese Materia Medica, CACMS; Shanghai Institute of Materia Medica, CAS; Second Affilitated Hospital of Tianjin University of TCM
- Start
- Jun 2015
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of qingkailing, sponsored by Institute of Chinese Materia Medica, CACMS; Shanghai Institute of Materia Medica, CAS; Second Affilitated Hospital of Tianjin University of TCM. Primary endpoints: Plasma drug concentration and Urinary drug concentration. Started Jun 2015; status: recruiting.
02
Drugs
qingkailing
Beyond the preview
Go deeper on ChiCTR-OPN-15006552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-15006552.